Articles tagged with: Neuroleptic Malignant Syndrome
ZYPREXA® RELPREVV™ (zy-PREX-a REL-prev) (olanzapine)
ZYPREXA® RELPREVV™ (zy-PREX-a REL-prev) (olanzapine)
For Extended Release Injectable Suspension
Medication Guide
Read the Medication Guide that comes with ZYPREXA RELPREVV before you start taking it and each time before you get an injection. There may be new …
ABILIFY MAINTENA® (a-BIL-i-fy main-TEN-a) (aripiprazole)
ABILIFY MAINTENA® (a-BIL-i-fy main-TEN-a) (aripiprazole)
for extended-release injectable suspension, for intramuscular use
MEDICATION GUIDE
What is the most important information I should know about ABILIFY MAINTENA?
Each injection of ABILIFY MAINTENA must be administered by a healthcare professional only.
ABILIFY …
SINEMET® CR 50 mg/200 mg Controlled-Release Tablets
SINEMET® CR 50 mg/200 mg Controlled-Release Tablets
NAME OF THE MEDICINAL PRODUCT
SINEMET® CR 50 mg/200 mg Controlled-Release Tablets
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet of ‘Sinemet CR’ contains carbidopa (equivalent to 50 mg of anhydrous carbidopa) …
ARISTADA® (air-is-TAH-dah) (aripiprazole lauroxil)
ARISTADA® (air-is-TAH-dah) (aripiprazole lauroxil)
extended-release injectable suspension, for intramuscular use
MEDICATION GUIDE
What is the most important information I should know about ARISTADA?
Each injection of ARISTADA must be administered by a healthcare professional only.
ARISTADA may cause serious side …
REXULTI® (REX-ul-TE) (brexpiprazole) Tablets
REXULTI® (REX-ul-TE) (brexpiprazole) Tablets
MEDICATION GUIDE
What is the most important information I should know about REXULTI?
REXULTI may cause serious side effects, including:
Increased risk of death in elderly people with dementia-related psychosis. Medicines like REXULTI can raise …
Latuda-lurasidone
Latuda-lurasidone
Package leaflet: Information for the patient
Latuda® 18.5 mg film-coated tablets; Latuda® 37 mg film-coated tablets; Latuda® 74 mg film-coated tablets
This medicine is subject to additional monitoring. This will allow quick identification of new safety …
